维普中文期刊产品整合服务
90篇 您的检索式:作者名="KASSOUF W"
    题名 作者 年代 出处 被引量
1Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer显示文摘Adam L Black PC Kassouf W 2007J U rol2007,177,5:1
2Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy 显示文摘Kassouf W Leibovici D Munsell M F 2006J Urol2006,176,1:1
3Update on the management of non-muscle invasive bladder cancer显示文摘Aldousari S Kassouf W 2010Can Urol Assoc J2010,4,1:1
4Distinctive expression patterns of ErbB family receptors signify an aggressive variant of bladder cancer显示文摘Kassouf W Black PC Tuziak T 2007J Urol2007,178,1:1
5Biomarkers for detection and surveillance of bladder cancer显示文摘Budman LI Kassouf W Steinberg JR 2008Can Urol Assoc J2008,,03:1
6Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy:results from the Canadian Upper Tract Collaboration显示文摘Fairey AS Kassouf W Estey E 2013BJU Int2013,112,6:1
7A critical analysis of orthotopic bladder substitutes in adult patients with bladder cancer:is there a perfect solution显示文摘Kassouf W Hautmann RE Bochner BH 0,,03:1
8Radical cystectomy is the treatment of choicefor invasive bladder cancer显示文摘Yafi FA Kassouf W 2009Can Urol Assoc J2009,3,40:1
9Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer显示文摘Kassouf W Black PC Tuziak T 2008Journal of Urology2008,179,1:1
10Effect of prostate volume on tumor grade in patients undergoing radical prostatectomy in the era of extended prostatic biopsies 显示文摘Kassouf W N akanishi H Ochlai A 2007J Urol2007,178,1:1
11Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails显示文摘Kassouf W Tanguay S Aprikian AG 2003J Urol2003,169,5:1
12Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells显示文摘Kassouf W Dinner CP Brow G 2005Cancer Res2005,65,10:1
13Is vascular endothelial growth factor modulation a predictor of the therapeutic efficacy of gefitinib for bladder cancer?显示文摘Kassouf W Brown GA Black PC 2008J Urol2008,180,3:1
14Cy- toreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology显示文摘KASSOUF W SANCHEZ ORTIZ R TAMBOLI P 2007J Urol2007,178,5:1
15P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors显示文摘Kassouf W Spiess PE Brown GA 2007Eur Uro12007,52,:1
16Is vascular endothelial growth factor modulation a predictor of the therapeutic efficacy of gefitinib for bladder cancer ? 显示文摘Kassouf W Brown GA Black PC 2008J Urol2008,180,3:1
17Organ preservation for muscle-invasive bladder cancer by transurethral resection 显示文摘Leibovici D Kassouf W Pisters LL 2007Urology2007,70,3:1
18A critical analysis of orthotopic bladder substitutes in adult patients with bladder cancer: is there a perfect solution? 显示文摘Kassouf W Hautmann R E Boehner B H 2010Eur Urol2010,58,3:1
19Management of urethral recurrence after orthotopic urinary diversion显示文摘Taylor JM Spiess PE Kassouf W 2010BJU Int2010,106,1:1
20Organ preservation for muscle-invasive bladder cancer by transurethral resection显示文摘Leibovici D Kassouf W Pisters L L 2007Urology2007,70,3:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费